A clinical trial of folic acid in Parkinson's disease.
作者信息
McGeer P L, Zeldowicz L, McGeer E G
出版信息
Can Med Assoc J. 1972 Jan 22;106(2):145-6 passim.
Abstract
摘要
相似文献
1
A clinical trial of folic acid in Parkinson's disease.帕金森病中叶酸的一项临床试验。
Can Med Assoc J. 1972 Jan 22;106(2):145-6 passim.
2
Rotigotine: Parkinson's disease: a step backward.罗替戈汀：帕金森病：一次倒退。
Prescrire Int. 2008 Apr;17(94):60.
3
[Parkinson's disease].
Tanpakushitsu Kakusan Koso. 1984 Dec;29(14):1801-14.
4
[Treatment of Parkinson's disease with amantadine].
Therapeutique. 1972 Nov;48(9):555-60.
5
[Uncertain effects of folic acid on disorders other than neural-tube defects].[叶酸对神经管缺陷以外疾病的不确定影响]
Ned Tijdschr Geneeskd. 2006 Jul 1;150(26):1439-42.
6
An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.帕金森病的间歇性、控速、缓慢进行性退变模型：息宁的抗帕金森病作用及哌甲酯的保护作用
Behav Brain Res. 2005 Jan 30;156(2):201-13. doi: 10.1016/j.bbr.2004.05.024.
7
Controlled trial of amantadine hydrochloride in Parkinson's disease.
N Z Med J. 1971 May;73(468):263-7.
8
[Clinical study of L-dopa in Parkinson's disease].左旋多巴治疗帕金森病的临床研究
Brux Med. 1972 Dec;52(12):851-60.
9
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.在帕金森病大鼠模型中，分子氢对6-羟基多巴胺诱导的黑质纹状体变性具有保护作用。
Neurosci Lett. 2009 Apr 3;453(2):81-5. doi: 10.1016/j.neulet.2009.02.016. Epub 2009 Feb 12.
10
[Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
Shinkei Kenkyu No Shimpo. 1971;15(1):267-85.
引用本文的文献
1
Initiation of treatment in early PD (evidences based).早期帕金森病的治疗起始（基于证据）
Ann Indian Acad Neurol. 2011 Jul;14(Suppl 1):S6-S10.
本文引用的文献
1
Some characteristics of brain tyrosine hydroxylase.脑酪氨酸羟化酶的一些特性。
Can J Biochem. 1967 Oct;45(10):1557-63. doi: 10.1139/o67-185.
2
Aseptic addition method for Lactobacillus casei assay of folate activity in human serum.用于检测人血清中叶酸活性的干酪乳杆菌测定的无菌添加法。
J Clin Pathol. 1966 Jan;19(1):12-6. doi: 10.1136/jcp.19.1.12.
3
Tyrosine hydroxylase.酪氨酸羟化酶
Pharmacol Rev. 1966 Mar;18(1):43-51.
4
On the role of pteridines as cofactors for tyrosine hydroxylase.论蝶啶作为酪氨酸羟化酶辅因子的作用。
Biochem Biophys Res Commun. 1965 Jun 9;19(6):708-15. doi: 10.1016/0006-291x(65)90315-3.
5
Urinary metabolites in Parkinson's disease.
Nature. 1968 Jan 13;217(5124):136-8. doi: 10.1038/217136a0.
6
Distribution of tyrosine hydroxylase in human and animal brain.
J Neurochem. 1971 Sep;18(9):1647-58. doi: 10.1111/j.1471-4159.1971.tb03738.x.
7
Toxicity of folic acid given in pharmacological doses to healthy volunteers.
Lancet. 1970 Jan 10;1(7637):61-3. doi: 10.1016/s0140-6736(70)91845-3.
8
Cholinergic enzyme systems in Parkinson's disease.
Arch Neurol. 1971 Sep;25(3):265-8. doi: 10.1001/archneur.1971.00490030091011.
Zotero 插件